News

Corona bridging loan for startups, scale-ups likely available from end of April

Last Tuesday, April 7, the Dutch cabinet announced that it will initially make € 100 million available for bridging loans to start-ups, scale-ups and innovative SMEs that have been financially affected by the impact of the corona crisis.
Corona bridging loan for startups, scale-ups likely available from end of April

Venture Challenge Alumnus AGILeBiotics contributes to fight against future pandemic infections (e.g. COVID-19)

Today we are reminded that antibiotics are an important part of treatment regiments not only for severe antiviral infections, such as COVID-19, but also other hospitalized patients with multidrug-resistant (MDR) secondary infections
Venture Challenge Alumnus AGILeBiotics contributes to fight against future pandemic infections (e.g. COVID-19)

AGILeBiotics appoints new CEO Victor Schut

Victor Schut has been appointed as the new Chief Executive Officer (CEO) of AGILeBiotics and co-founder Dr. Andreas A. Bastian has now taken on the role of Chief Operating Officer (COO).
AGILeBiotics appoints new CEO Victor Schut

Six teams selected for the Venture Challenge Spring 2020 - Workshops postponed due to COVID-19 restrictions

Six teams have been selected by NWO for participation in the Venture Challenge Spring 2020 edition.
Six teams selected for the Venture Challenge Spring 2020 - Workshops postponed due to COVID-19 restrictions

Venture Challenge Alumnus Toxys Raises €2 Million Financing for Global Expansion of its Unique Animal-Free Chemical Safety Tests

Venture Challenge Alumnus Toxys is an innovative Dutch biotech company that develops unique animal-free labo
Venture Challenge Alumnus Toxys Raises €2 Million Financing for Global Expansion of its Unique Animal-Free Chemical Safety Tests

Prolira - Delirium awareness day

Early detection of delirium, quick intervention and good monitoring is of great importance to prevent (permanent) consequential damage.
Prolira - Delirium awareness day

Cyclomics and University Medical Center Utrecht sign collaboration agreement

Following the licensing of liquid biopsy technology owned by the University Medical Center Utrecht (UMC Utrecht), Cyclomics and the UMC Utrecht have entered into a long-standing collaboration to strengthen the synergy between both parties f
Cyclomics and University Medical Center Utrecht sign collaboration agreement

Venture Challenge Fall 2019: Meet the teams

Last week the Venture Challenge Fall 2019 kicked off with five Life Sciences & Health startups participating in the first bootcamp at Pivot Park.
Meet the teams Venture Challenge Fall 2019

Venture Challenge Spring 2019: Meet the teams

Every year LifeSciences@Work organises two Venture Challenges for start-ups that want to translate their idea into a solid business case.
Meet the teams Venture Challenge Spring 2019

Venture Challenge Fall 2018: Meet the participants

Every year LifeSciences@Work organises two Venture Challenges for startups that want to develop their idea into a solid business case.
Venture Challenge Fall 2018